Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

Contract Win

20 Nov 2008 07:00

RNS Number : 5213I
e2v technologies PLC
20 November 2008
 



20 November  2008 

e2v technologies plc

Contract Win 

e2v technologies, a specialist developer and manufacturer of high technology components and sub-systems, announces an £11m contract renewal to supply Varian Medical Systems, Inc., headquartered in Palo Alto, US, with electron devices for incorporation into linear accelerators, for use in radiotherapy cancer treatment and cargo screening systems.

The contract will be worth at least £11m (payments will be in US dollars at the prevailing exchange rate) over two years, and is the first of a number of anticipated multi-year contract renewals for electron devices used in linear accelerators. e2v's products generate and deliver the microwave power required from the linear accelerator to produce X-rays used in both the imaging and radiation treatment of tumours as well as the imaging systems within cargo screening equipment.

This contract represents an increase in business with this customer, has the potential to increase in value over the term of the agreement, and is in line with management's growth expectations for this sector.

Keith Attwood, Chief Executive of e2v said: ``This multi-year contract renewal with Varian is a demonstration of the strong and close relationships we build with our strategic partners.''

For further information:

e2v technologies plc

Tel: +44 (0)1245 493493

Keith Attwood/Mike Hannant

www.e2v.com

Financial Dynamics

Tel: +44 (0)20 7269 7225

Jon Simmons/Sophie Kernon

   

NOTES FOR EDITORS

e2v 

e2v's objective is to be a global leader in the design and supply of specialised components and sub-systems that enable the world's leading systems companies to deliver innovative solutions for medical and science, aerospace and defence, and commercial and industrial markets.

e2v has 4 major product groups:

High performance electron devices and subsystems for applications including defence electronic countermeasures, radiotherapy cancer treatment, and radar systems

Advanced Imaging sensors and cameras for applications including industrial process control, dental X-ray systems, space science and life sciences

Specialist semiconductors, including logic, memory and microprocessors for high reliability mission-critical programs in avionics, defence and telecommunications, sensor data acquisition, and high speed data conversion

A range of professional sensing products for applications including fire, rescue and security thermal imaging, X-ray spectroscopy, and military surveillance, targeting and guidance

For the year ended 31 March 2008, e2v achieved sales of £205m and is listed on the London Stock Exchange. In October 2008 e2v acquired QP semiconductor, a leading US-based designer and supplier of specialty semiconductor components used in military and aerospace applications, establishing e2v's first US manufacturing base. 

The Company is headquartered in the United Kingdom and has approximately 1800 employees in six production facilities across Europe and North America. e2v also operates a global network of sales and technical support offices, supported by local distributors and resellers.

Further information is available from www.e2v.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTFKCKDABDDFDD
Date   Source Headline
30th Sep 20097:00 amRNSAmendment to debt facilities
25th Sep 20097:00 amRNSAppointment of New Chairman
17th Sep 20093:39 pmRNSNotification of Interest in Shares
15th Sep 20094:47 pmRNSNotification of Interest in Shares
8th Sep 20093:34 pmRNSTotal Voting Rights
3rd Sep 20095:11 pmRNSNOTIFICATION OF MAJOR INTERESTS IN SHARES
28th Aug 20094:35 pmRNSPrice Monitoring Extension
7th Aug 20091:50 pmRNSTotal Voting Rights
31st Jul 20094:43 pmRNSSummary of Proxy Votes
31st Jul 20094:37 pmRNSResult of AGM
30th Jul 20097:00 amRNSInterim Management Statement
20th Jul 20095:15 pmRNS2009 Annual Report and Accounts
24th Jun 20093:37 pmRNSLong Term Incentive Plan
19th Jun 20094:40 pmRNSSecond Price Monitoring Extn
19th Jun 20094:35 pmRNSPrice Monitoring Extension
18th Jun 20093:42 pmRNSDirectorate Change
8th Jun 20097:00 amRNSFinal Results
2nd Jun 20094:35 pmRNSPrice Monitoring Extension
29th May 20094:42 pmRNSPrice Monitoring Extension
29th May 20094:36 pmRNSPrice Monitoring Extension
29th May 20099:30 amRNSDirectorate Change
7th May 200910:13 amRNSNOTIFICATION OF MAJOR INTERESTS IN SHARES
5th May 20097:00 amRNSAppointment of Group Finance Director
28th Apr 20097:00 amRNSContract
24th Apr 20094:40 pmRNSSecond Price Monitoring Extn
24th Apr 20094:36 pmRNSPrice Monitoring Extension
15th Apr 20094:40 pmRNSSecond Price Monitoring Extn
15th Apr 20094:35 pmRNSPrice Monitoring Extension
9th Apr 20099:39 amRNSNotification of Major Interests In Shares
7th Apr 20093:08 pmRNSNotification Of Major Interests In Shares
6th Apr 20097:00 amRNS2009 Year End Trading Update
27th Mar 20092:35 pmRNSNOTIFICATION OF MAJOR INTERESTS IN SHARES
27th Mar 20092:33 pmRNSDirectorate Change of Responsibility
24th Mar 20093:54 pmRNSNOTIFICATION OF MAJOR INTERESTS IN SHARES
24th Mar 20093:51 pmRNSNOTIFICATION OF MAJOR INTERESTS IN SHARES
20th Mar 20099:24 amRNSNotification of Major Interests in Shares
16th Mar 20095:23 pmRNSNotification of Major Interests in Shares
16th Mar 20095:16 pmRNSNotification of Major Interests in Shares
9th Mar 20097:00 amRNSe2v secures ?18.3m contract renewal
9th Feb 20097:00 amRNSDirectorate Change
26th Jan 20097:00 amRNSInterim Management Statement
20th Jan 20099:17 amRNSNotification of Major Interests in Shares
9th Jan 20099:25 amRNSNotification of Major Interests in Shares
6th Jan 20097:00 amRNSe2v secures major contract renewals
23rd Dec 20082:51 pmRNSNOTIFICATION OF MAJOR INTERESTS IN SHARES
23rd Dec 20082:49 pmRNSNOTIFICATION OF MAJOR INTERESTS IN SHARES
22nd Dec 20083:55 pmRNSNOTIFICATION OF MAJOR INTERESTS IN SHARES
19th Dec 20084:42 pmRNSSecond Price Monitoring Extn
19th Dec 20084:37 pmRNSPrice Monitoring Extension
19th Dec 20087:00 amRNSe2v secures contract renewal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.